Correction: ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party.
Penack O, Peczynski C, Boreland W, Lemaitre J, Reinhardt HC, Afanasyeva K, Avenoso D, Holderried TAW, Kornblit BT, Gavriilaki E, Martinez C, Chiusolo P, Mico MC, Daguenet E, Wichert S, Ozdogu H, Piekarska A, Kinsella F, Basak GW, Schoemans H, Koenecke C, Moiseev I, Peric Z.
Penack O, et al. Among authors: holderried taw.
Bone Marrow Transplant. 2024 Oct 18. doi: 10.1038/s41409-024-02435-8. Online ahead of print.
Bone Marrow Transplant. 2024.
PMID: 39424959
No abstract available.